Salt Lake City, UT · Founded 2019 · Privately Held (backing)
Developer of an epigenetic medicine platform designed to tackle health issues by overhauling the trial-and-error methodology. Inherent Biosciences is based in Salt Lake City, UT and was founded in 2019. It was valued at $18.1 million at its early-stage round in Sep 2022, the last priced event on record. It has raised $9.8 million across 1 recorded round; the latest was a $1.5 million seed round in Aug 2022.
PMV mark · valuation
$18.1M
Oct 2026
Priced at
its early-stage round
Sep 2022
Total raised
$9.8M
Last round
Seed Round
Aug 2022
Cap table — not yet on record
Inherent Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Inherent Biosciences with a free account
·The complete investor list: 18 names
·Watch Inherent Biosciences: the Monday email on marks, rounds and moves
Where does Inherent Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Inherent Biosciences's 1 recorded funding rounds.
